Immunomedics (IMMU)
Add to Watchlists Create an Alert
3.275
+0.14 +4.30%
NASDAQ
May 23, 4:59PM
BATS Real time
Currency in USD
Immunomedics Free Cash Flow:
-4.091M for Dec. 31, 2012Immunomedics Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -4.091M |
| Sept. 30, 2012 | -7.437M |
| June 30, 2012 | -6.369M |
| March 31, 2012 | 21.13M |
| Dec. 31, 2011 | -4.532M |
| Sept. 30, 2011 | -6.247M |
| June 30, 2011 | 3.137M |
| March 31, 2011 | -6.374M |
| Dec. 31, 2010 | -1.849M |
| Sept. 30, 2010 | -7.417M |
| June 30, 2010 | 0.4215M |
| March 31, 2010 | 0.7197M |
| Dec. 31, 2009 | -1.512M |
| Sept. 30, 2009 | -7.383M |
| June 30, 2009 | -4.420M |
| March 31, 2009 | -4.711M |
| Dec. 31, 2008 | -3.964M |
| Sept. 30, 2008 | 33.80M |
| June 30, 2008 | -6.304M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
IMMU Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Seattle Genetics | 44.99M |
| AVEO Pharmaceuticals | -29.14M |
| Threshold Pharmaceuticals | 33.47M |
IMMU Free Cash Flow Rankings
| Overall |
58th percentile 3291 of 8006 |
| Sector |
46th percentile 370 of 686 in Healthcare |
| Industry |
66th percentile 84 of 248 in Biotechnology |
IMMU Free Cash Flow Range, Past 5 Years
| Minimum | -7.437M | Sep 2012 |
| Maximum | 33.80M | Sep 2008 |
| Average | -0.7052M |